As of 2025-12-25, the Relative Valuation of EyePoint Pharmaceuticals Inc (EYPT) is (38.71) USD. This relative valuation is based on P/E multiples. With the latest stock price at 18.26 USD, the upside of EyePoint Pharmaceuticals Inc based on Relative Valuation is -312.0%.
The range of the Relative Valuation is (28.98) - (39.91) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.7x - 16.1x | 14.2x |
| Forward P/E multiples | 11.7x - 18.6x | 17.0x |
| Fair Price | (28.98) - (39.91) | (38.71) |
| Upside | -258.7% - -318.6% | -312.0% |
| Date | P/E |
| 2025-12-24 | -7.35 |
| 2025-12-23 | -7.40 |
| 2025-12-22 | -7.58 |
| 2025-12-19 | -7.01 |
| 2025-12-18 | -6.86 |
| 2025-12-17 | -6.70 |
| 2025-12-16 | -6.81 |
| 2025-12-15 | -6.60 |
| 2025-12-12 | -6.43 |
| 2025-12-11 | -6.48 |
| 2025-12-10 | -6.73 |
| 2025-12-09 | -6.87 |
| 2025-12-08 | -7.17 |
| 2025-12-05 | -7.14 |
| 2025-12-04 | -6.73 |
| 2025-12-03 | -5.84 |
| 2025-12-02 | -5.51 |
| 2025-12-01 | -5.74 |
| 2025-11-28 | -5.97 |
| 2025-11-26 | -5.95 |
| 2025-11-25 | -5.93 |
| 2025-11-24 | -5.79 |
| 2025-11-21 | -5.50 |
| 2025-11-20 | -5.49 |
| 2025-11-19 | -5.75 |
| 2025-11-18 | -5.62 |
| 2025-11-17 | -5.29 |
| 2025-11-14 | -4.66 |
| 2025-11-13 | -4.63 |
| 2025-11-12 | -4.82 |
| 2025-11-11 | -4.69 |
| 2025-11-10 | -4.57 |
| 2025-11-07 | -4.51 |
| 2025-11-06 | -4.46 |
| 2025-11-05 | -4.43 |
| 2025-11-04 | -4.99 |
| 2025-11-03 | -5.01 |
| 2025-10-31 | -5.27 |
| 2025-10-30 | -4.91 |
| 2025-10-29 | -4.72 |
| 2025-10-28 | -4.93 |
| 2025-10-27 | -4.87 |
| 2025-10-24 | -4.82 |
| 2025-10-23 | -4.63 |
| 2025-10-22 | -4.61 |
| 2025-10-21 | -4.75 |
| 2025-10-20 | -4.84 |
| 2025-10-17 | -4.68 |
| 2025-10-16 | -4.65 |
| 2025-10-15 | -4.72 |